BNTX News and Press, BioNTech SE From 02/02/23

Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugs The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing an important starting material for its oncology and COVID-19 vaccine pipeline...

Summary Genmab (GMAB) is a Danish commercial biopharma company with a leading technology and track record in innovative antibody-based therapeutics. Darzalex royalty revenue is the key driver of the stock price and the bedrock of Genmab's strong performance during 2021-2022. We expe...

Summary Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. They increased NVIDIA, Shopify, NIO Inc., SEA Ltd., Roblox, DoorDash, and Ginkgo Bioworks while reducing Illumina, Ferrari N.V., Arthur J. Gallagher & Co., Albemarle, Meta Platform...

Omicron subvariant XBB.1.5 continues to account for a greater proportion of COVID-19 cases across the US with the latest CDC data finding it responsible for 61.3%. For the week ending Jan. 28, XBB.1.5 is now easily outrunning previously dominant BQ.1.1 and BA.5 subvariants which made up ~27% ...

Summary Wall Street has gone downgrade happy on Pfizer in January, loudly complaining the end of the pandemic has arrived. What brokerage analysts are failing to appreciate is Pfizer now has the strongest balance sheet and free cash flow setup in Big Pharma. If you like cash holding...

A panel of advisors to the US FDA has suggested that individuals get COVID-19 updated shots on a regular basis to keep up with new variants. The Vaccines and Related Vaccines Biological Products Advisory Committee agreed that additional information on how the vaccines are working in the popul...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips What are the hot stocks for tomorrow, Thursday, Jan. 25? You probably already know that the headlines are going to be dominated by earnings. That’s particularly true as we started hearing from a bunch of companies on T...

Ahead of an advisory committee meeting this week, the FDA said that similar to flu vaccinations, the annual administration of updated COVID-19 vaccines will be appropriate against a fast-changing virus. “…experience from influenza vaccine strain composition changes for U.S. vacc...

Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...

Summary Novartis is one of the world’s most successful pharma companies and it is undergoing a major change to become a pure-play innovative medicines company. Part of this also involves Novartis pursuing a “US-First mindset”, which might prefer money at the expense...